Baillie Gifford - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 123 filers reported holding CARDLYTICS INC in Q4 2022. The put-call ratio across all filers is 1.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of CARDLYTICS INC
ValueSharesWeighting
Q2 2023$9,104,858
+87.9%
1,440,642
+1.0%
0.01%
+100.0%
Q1 2023$4,844,465
-41.6%
1,426,941
-0.6%
0.00%
-55.6%
Q4 2022$8,301,352
-19.6%
1,436,220
+30.7%
0.01%
-18.2%
Q3 2022$10,331,000
-59.4%
1,098,968
-3.7%
0.01%
-57.7%
Q2 2022$25,454,000
-56.2%
1,140,911
+8.0%
0.03%
-36.6%
Q1 2022$58,071,000
-4.3%
1,056,208
+15.1%
0.04%
+24.2%
Q4 2021$60,662,000
-3.1%
917,876
+23.1%
0.03%0.0%
Q3 2021$62,602,000
+0.3%
745,804
+51.6%
0.03%
+10.0%
Q2 2021$62,432,000
+27.7%
491,868
+10.4%
0.03%
+11.1%
Q1 2021$48,890,000445,6770.03%
Other shareholders
CARDLYTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
CAS Investment Partners, LLC 5,149,591$432,257,00020.60%
Antipodean Advisors LLC 638,800$53,621,00015.18%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 400,545$33,622,00014.40%
KPS Global Asset Management UK Ltd 1,176,830$98,783,00013.48%
Oakcliff Capital Partners, LP 271,447$22,785,00010.09%
BERYLSON CAPITAL PARTNERS, LLC 189,800$15,932,0007.37%
Alua Capital Management LP 1,244,259$104,443,0005.39%
683 Capital Management, LLC 1,465,219$122,990,0004.80%
Selkirk Management LLC 70,600$5,926,0002.41%
Covey Capital Advisors, LLC 34,265$2,876,0002.30%
View complete list of CARDLYTICS INC shareholders